Hormone-positive breast cancer (where the disease relies on hormones to grow) is the most common subtype of the disease and has a wide array of treatment options — even for those with metastatic ...

Outcomes for patients with metastatic HER2-positive breast cancer have improved as a result of research helping health care providers to understand the mechanisms of the protein, which has led to the ...